Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 149,555 | 76,436 | 22,881 | 150,245 | 65,871 |
| Cost of Goods | 12 | 5,291 | 7,203 | 965 | N/A |
| Gross Profit | 149,543 | 71,145 | 15,678 | 149,280 | 65,871 |
| Operating Expenses | 251,643 | 240,806 | 267,883 | 223,007 | 132,013 |
| Operating Income | -102,088 | -169,370 | -252,002 | -72,762 | -66,142 |
| Interest Expense | 31,096 | 21,166 | 21,002 | 59 | 63 |
| Other Income | -9,485 | 918 | 192 | 197 | 1,356 |
| Pre-tax Income | -142,669 | -189,618 | -272,812 | -72,624 | -64,849 |
| Income Tax | N/A | N/A | N/A | N/A | 3 |
| Net Income Continuous | -142,669 | -189,618 | -272,812 | -72,624 | -64,852 |
| Net Income | $-142,669 | $-189,618 | $-272,812 | $-72,624 | $-64,852 |
| EPS Basic Total Ops | -1.00 | -1.39 | -2.35 | -0.68 | -0.65 |
| EPS Basic Continuous Ops | -1.00 | -1.39 | -2.35 | -0.68 | -0.65 |
| EPS Diluted Total Ops | -1.00 | -1.39 | -2.35 | -0.68 | -0.65 |
| EPS Diluted Continuous Ops | -1.00 | -1.39 | -2.35 | -0.68 | -0.65 |
| EBITDA(a) | $-90,458 | $-157,039 | $-240,273 | $-61,437 | $-56,143 |